Adalimumab/efalizumab/etanercept/infliximab: Various toxicities: 19 case reports

Author:  

Publisher: Adis International

ISSN: 0114-9954

Source: Reactions Weekly, Vol.1, Iss.1387, 2012-01, pp. : 5-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract